Medical Health & Life Science Research News

Research focused on the injectable drug delivery market growing at 11.5% CAGR in the forecast period 2017-2024

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024

- Advertisement -
- Market Research Pro -

Global injectable drug delivery is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Request Sample Report: Global Injectable Drug Delivery Market – Industry Trends and Forecast to 2024

Market Segmentation:

The global injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.

MAJOR MARKET DRIVERS:

  1. RISING CASES OF CHRONIC DISEASE
  2. RISING DEMAND OF SELF-INJECTION DEVICES
  3. GROWTH OF BIOLOGICS MARKET

On the basis of type market is segmented into Devices and Formulations where as Devices are segmented into Conventional Injection, Self-Injection and Formulations Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

- Advertisement -
- Market Research Pro -

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others

Enquiry about the report: Global Injectable drug delivery Market 

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The countries covered in this report are U.S.

Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

image

For More Market and Industry Trends:  Global Injectable Drug Delivery Market Is Growing At A Significant Rate In The Forecast Period 2017-2024

Global Player Operating in the Global Injectable Drug Delivery Market:

  • Baxter International, Inc.,
  • Becton Dickinson and Company,
  • Gerresheimer AG,
  • Pfizer, Inc.,
  • Schott AG,
  • Alkermes Plc.,
  • Eli Lilly and Company,
  • Sandoz,
  • Terumo Corporation,
  • Teva Pharmaceuticals Industries Ltd.,
  • Bespak,
  • Antares Pharma,
  • Elcam Medical,
  • Haselmeier,
  • Mylan N.V.,
  • Novo Nordisk,
  • Owen Mumford Ltd,
  • Sanofi,
  • West Pharmaceutical Services, Inc,
  • Ypsomed Holding AG

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experie ...